You are here

  • Home
  • Archive
  • Volume 11, Issue 6
  • Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapy

Article metrics

Article menu

This article has a correction. Please see:

Immune cell therapies and immune cell engineering
Original research
Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapy

 

Online download statistics by month:

Online download statistics by month: June 2023 to February 2026

AbstractFullPdf
Jun 202357583
Jul 202314361455450
Aug 2023590594178
Sep 2023405405140
Oct 2023344348164
Nov 2023361361140
Dec 202321721984
Jan 202413613673
Feb 202418818959
Mar 202421421776
Apr 202418318447
May 202426526769
Jun 202416516450
Jul 202426326761
Aug 202418618852
Sep 2024189191318
Oct 202419119567
Nov 202415816054
Dec 202413113242
Jan 202511611858
Feb 202530030268
Mar 202514915374
Apr 202517417457
May 202510710744
Jun 2025888946
Jul 2025330
Sep 2025110
Oct 2025550
Jan 2026001
Feb 2026110
Total662366832475